Stock Track | Novavax Soars 5.34% in Pre-market as Vaccine Sector Rises on Moderna's Hantavirus Research

Stock Track

05/11

Novavax's stock soared 5.34% in pre-market trading on Monday, following positive momentum in the vaccine sector.

The surge appears to be part of a broader rally among vaccine makers, with Moderna's shares also climbing premarket after the company reported preclinical research on hantaviruses in collaboration with the U.S. Army Medical Research Institute of Infectious Diseases. Moderna also has a research agreement with Korea University to develop an mRNA-based vaccine for hantavirus.

This positive development for Moderna has created bullish sentiment across the vaccine sector, benefiting other companies like Novavax and Inovio, which also saw pre-market gains.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1120855611"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1120855611\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1120855611?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-11 21:29","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1120855611","market":"hk","top_or_hot":-1,"title":"Stock Track | Novavax Soars 5.34% in Pre-market as Vaccine Sector Rises on Moderna's Hantavirus Research","media":"Stock Track","content":"<p>Novavax's stock soared 5.34% in pre-market trading on Monday, following positive momentum in the vaccine sector.</p><p>The surge appears to be part of a broader rally among vaccine makers, with Moderna's shares also climbing premarket after the company reported preclinical research on hantaviruses in collaboration with the U.S. Army Medical Research Institute of Infectious Diseases. Moderna also has a research agreement with Korea University to develop an mRNA-based vaccine for hantavirus.</p><p>This positive development for Moderna has created bullish sentiment across the vaccine sector, benefiting other companies like Novavax and Inovio, which also saw pre-market gains.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Novavax Soars 5.34% in Pre-market as Vaccine Sector Rises on Moderna's Hantavirus Research</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Novavax Soars 5.34% in Pre-market as Vaccine Sector Rises on Moderna's Hantavirus Research\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time smaller\">2026-05-11 21:29</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Novavax's stock soared 5.34% in pre-market trading on Monday, following positive momentum in the vaccine sector.</p><p>The surge appears to be part of a broader rally among vaccine makers, with Moderna's shares also climbing premarket after the company reported preclinical research on hantaviruses in collaboration with the U.S. Army Medical Research Institute of Infectious Diseases. Moderna also has a research agreement with Korea University to develop an mRNA-based vaccine for hantavirus.</p><p>This positive development for Moderna has created bullish sentiment across the vaccine sector, benefiting other companies like Novavax and Inovio, which also saw pre-market gains.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"NVAX","symbol_name":"諾瓦瓦克斯醫藥","start_time":0,"source_url":"","article_id":"1120855611","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1120855611","pubTimestamp":1778506189,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Novavax's stock soared 5.34% in pre-market trading on Monday, following positive momentum in the vaccine sector.The surge appears to be part of a broader rally among vaccine makers, with Moderna's...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"translate_title":"个股追踪|Novavax盘前大涨5.34%疫苗板块因Moderna汉坦病毒研究而上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NVAX":1},"content_text":"Novavax's stock soared 5.34% in pre-market trading on Monday, following positive momentum in the vaccine sector.The surge appears to be part of a broader rally among vaccine makers, with Moderna's shares also climbing premarket after the company reported preclinical research on hantaviruses in collaboration with the U.S. Army Medical Research Institute of Infectious Diseases. Moderna also has a research agreement with Korea University to develop an mRNA-based vaccine for hantavirus.This positive development for Moderna has created bullish sentiment across the vaccine sector, benefiting other companies like Novavax and Inovio, which also saw pre-market gains.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}